When is chemotherapy recommended for neuroblastoma?

Neuroblastoma is a childhood cancer that develops from immature nerve cells, often near the adrenal glands or along the spine. Treatment is tailored using the child's age, tumour biology, location, imaging findings, whether the cancer has spread and how it responds to early treatment.

For high-risk disease, chemotherapy may be one stage of multimodal care that can also include surgery, radiotherapy, stem-cell rescue, or medicines that target remaining cancer cells. It may be used to shrink a tumour before surgery, treat disease that has spread, or clear persistent disease after an operation.

Ask the paediatric oncology team to explain the treatment sequence, hospital visits, blood-test schedule and infection plan. Tell them about medicines, allergies, feeding problems, constipation, pain and any change in movement or behaviour. Arrange help with transport, siblings, school routines and meals, and ask about a central line if medicines will be given repeatedly.

Keep written instructions for temperature checks, medicines and the emergency contact number. Gentle mouth care and adequate fluids may help, but follow the team's instructions when blood counts are low.

Call the paediatric oncology service immediately for fever or chills, unusual sleepiness, breathing difficulty, repeated vomiting, inability to drink or fewer wet nappies than expected. Emergency care is needed for a seizure, collapse, uncontrolled bleeding, sudden weakness, severe pain or a rapidly enlarging abdomen. Follow the team's own fever threshold and instructions because they are specific to the child.

What risk group does my child have, and what makes chemotherapy necessary? Is the aim to shrink the tumour, treat spread or prepare for another treatment? How will response and side effects be checked? What temperature or symptom requires an immediate call?